Literature DB >> 19614807

Hypertension in athletes.

John J Leddy1, Joseph Izzo.   

Abstract

Regular physical activity and training are associated with reductions in blood pressure (BP), yet elevated BP is one of the most common abnormalities found during the pre-participation physical evaluation of athletes. Hypertension (HTN) remains the most common cardiovascular condition encountered in athletic populations, therefore all athletes require screening for HTN. Because athletes often have white coat HTN, BP recordings outside the office are also necessary. The 36th Bethesda Conference classified sports according to their varying physiologic demands and provided specific recommendations for the evaluation, treatment, and sport participation of athletes with HTN. In general, angiotensin-converting enzyme inhibitors and other vasodilators are the medications of choice for active and athletic patients because of their limited interference with cardiovascular conditioning. Other agents can be used but some sports governing bodies proscribe the use of certain antihypertensive medications such as beta-blockers for elite athletes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614807      PMCID: PMC8673157          DOI: 10.1111/j.1751-7176.2009.00100.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

1.  Pressure amplification explains why pulse pressure is unrelated to risk in young subjects.

Authors:  I B Wilkinson; S S Franklin; I R Hall; S Tyrrell; J R Cockcroft
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

Review 2.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 3.  Task Force 8: classification of sports.

Authors:  Jere H Mitchell; William Haskell; Peter Snell; Steven P Van Camp
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

Review 4.  The clinical significance of white-coat and masked hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Roberto Gattobigio; Claudia Borgioni; Claudia Castellani; Mariagrazia Sardone; Gianpaolo Reboldi
Journal:  Blood Press Monit       Date:  2007-12       Impact factor: 1.444

5.  Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects.

Authors:  M Soergel; M Kirschstein; C Busch; T Danne; J Gellermann; R Holl; F Krull; H Reichert; G S Reusz; W Rascher
Journal:  J Pediatr       Date:  1997-02       Impact factor: 4.406

6.  Suspicion of aortic coarctation in an outpatient clinic: how should blood pressure measurements be performed?

Authors:  E Rahiala; T Tikanoja
Journal:  Clin Physiol       Date:  2001-01

7.  White coat hypertension detected during screening of male adolescent athletes.

Authors:  E Kouidi; A Fahadidou-Tsiligiroglou; E Tassoulas; A Deligiannis; A Coats
Journal:  Am J Hypertens       Date:  1999-02       Impact factor: 2.689

Review 8.  Management of hypertension in pregnancy.

Authors:  N A Chung; D G Beevers; G Y Lip
Journal:  Am J Cardiovasc Drugs       Date:  2001       Impact factor: 3.571

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Effect of "no added salt diet" on blood pressure control and 24 hour urinary sodium excretion in mild to moderate hypertension.

Authors:  Javad Kojuri; Rahim Rahimi
Journal:  BMC Cardiovasc Disord       Date:  2007-11-06       Impact factor: 2.298

View more
  3 in total

Review 1.  Hypertension in Athletes and Active Populations.

Authors:  Kevin T Schleich; M Kyle Smoot; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

2.  A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations.

Authors:  James M Smoliga; E Sage Colombo; Matthew J Campen
Journal:  Aging (Albany NY)       Date:  2013-07       Impact factor: 5.682

Review 3.  Primary hypertension and special aspects of hypertension in older children and adolescents.

Authors:  Demetrius Ellis; Yosuke Miyashita
Journal:  Adolesc Health Med Ther       Date:  2011-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.